MPLN will be using mScope Clinical for its pathology imaging communications and integration platform in a new partnership that signifies a major breakthrough with a market leader in comprehensive, personalized testing services

Aurora Interactive Ltd. has signed a license agreement for its mScope Clinical communications and imaging modalities integration platform with Molecular Pathology Laboratory Network, Inc. (MPLN), a leader in specialized reference laboratory services dedicated to providing superior diagnostic testing and complementary technologies, including molecular diagnostics, flow cytometry, fluorescence in situ hybridization, immunohistochemistry and cytogenetics.

“We chose Aurora for their cost-efficient plug-and-play and proven integration solution. Given the variety of imaging modalities we use, we considered Aurora’s universality key to maintaining our strategic flexibility and creating a common user interface for our internal and external clients,” said Steve Olsen, MS, HTL (ASCP), Chief Operating Officer of MPLN.

“We are very excited about MPLN’s decision to partner with Aurora. MPLN is a cutting edge provider who is dedicated to client service and making a difference in patient care. We are proud they chose us as their communications and integration partner” stated Pierre Le Fèvre, President and Chief Executive Officer, Aurora Interactive.

About Molecular Pathology Laboratory Network, Inc.

Molecular Pathology Laboratory Network, Inc. (MPLN) is a privately-owned regional reference laboratory founded in 1989 with headquarters in Maryville, Tenn. and a satellite laboratory in Richmond, Va. A leader in personalized laboratory medicine, MPLN specializes in oncology and women’s health testing and has extensive expertise in chromosome analysis, flow cytometry, fluorescence in situ hybridization (FISH), real-time and quantitative polymerase chain reaction technologies, anatomic pathology, immunohistochemistry and gene sequencing. The laboratory also offers research and development services through its clinical trial division, Geneuity Clinical Research Services. MPLN is certified by the Clinical Laboratory Improvement Amendments (CLIA), accredited by the College of American Pathologists (CAP), and licensed by the states of Tennessee, Florida, New York and Maryland. For more information about MPLN, visit www.mplnet.com

Molecular Pathology Laboratory Network, Inc. (MPLN) is a privately-owned regional reference laboratory founded in 1989 with headquarters in Maryville, Tenn. and a satellite laboratory in Richmond, Va.

A leader in personalized laboratory medicine, MPLN specializes in oncology and women’s health testing with extensive expertise in chromosome analysis, flow cytometry, fluorescence in situ hybridization (FISH), real-time and quantitative polymerase chain reaction technologies, anatomic pathology, immunohistochemistry and gene sequencing. The laboratory also offers research and development services through its clinical trial division, Geneuity Clinical Research Services.

MPLN is certified by the Clinical Laboratory Improvement Amendments (CLIA), accredited by the College of American Pathologists (CAP), and licensed by the states of Tennessee, Florida, New York and Maryland. For more information about MPLN, visit www.mplnet.com